1. Home
  2. BIIB
  3. BIIB News

Latest Biogen Inc. (BIIB) News on April 26, 2025

BIIB

MT Newswires

a day ago

RBC Cuts Price Target on Biogen to $217 From $225, Keeps Outperform Rating

Earnings Preview: Biogen Inc. (BIIB) Q1 Earnings Expected to Decline
BIIB

Zacks

2 days ago

Earnings Preview: Biogen Inc. (BIIB) Q1 Earnings Expected to Decline

1 Safe-and-Steady Stock with Promising Prospects and 2 to Ignore
BIIB

StockStory

2 days ago

1 Safe-and-Steady Stock with Promising Prospects and 2 to Ignore

Can Biogen Keep the Beat Streak Alive This Earnings Season?
BIIB

Zacks

2 days ago

Can Biogen Keep the Beat Streak Alive This Earnings Season?

Biogen’s Friedreich’s ataxia treatment authorised in UK
BIIB

Pharmaceutical Technology

2 days ago

Biogen’s Friedreich’s ataxia treatment authorised in UK

BIIB

MT Newswires

3 days ago

Goldman Sachs Adjusts Price Target on Biogen to $197 From $219, Maintains Buy Rating

BIIB

MT Newswires

4 days ago

RBC Lifts Price Target on Biogen to $225 From $221, Keeps Outperform Rating

BIIB

MT Newswires

9 days ago

BMO Capital Adjusts Biogen Price Target to $128 From $139

Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi
BIIB

Zacks

10 days ago

Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi

EC authorises Eisai and Biogen’s lecanemab for Alzheimer’s
BIIB

Pharmaceutical Technology

10 days ago

EC authorises Eisai and Biogen’s lecanemab for Alzheimer’s

BIIB

Associated Press Finance

10 days ago

European regulators OK Alzheimer's treatment Leqembi after initial doubts

BIIB

MT Newswires

10 days ago

Wedbush Cuts Biogen Price Target to $121 From $135, Maintains Neutral Rating

BIIB

MT Newswires

10 days ago

Update: Biogen, Eisai's Alzheimer's Drug Leqembi Approved in EU

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
BIIB

GlobeNewswire

11 days ago

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

BIIB

MT Newswires

11 days ago

Biogen, Eisai's Alzheimer's Drug Leqembi Approved in EU

BIIB

MT Newswires

11 days ago

Goldman Sachs Adjusts Biogen's Price Target to $219 From $245, Keeps Buy Rating

BIIB

MT Newswires

12 days ago

Goldman Sachs Cuts Price Target on Biogen to $219 From $245

BIIB

MT Newswires

15 days ago

Citigroup Adjusts Price Target on Biogen to $125 From $145, Keeps Neutral Rating

BIIB

Clinical Trials Arena

15 days ago

Alzheon’s Alzheimer’s pill fails in Phase III trial

BIIB

MT Newswires

16 days ago

Guggenheim Adjusts Price Target on Biogen to $165 From $190, Maintains Buy Rating

Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
BIIB

Investor's Business Daily

16 days ago

Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.

Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?
BIIB

Zacks

16 days ago

Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?

BIIB

MT Newswires

17 days ago

Morgan Stanley Adjusts Price Target on Biogen to $152 From $157, Keeps Equalweight Rating

BIIB

Morningstar Research

21 days ago

Analyst Report: Biogen Inc.

Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell?
BIIB

Investor's Business Daily

22 days ago

Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell?

BIIB

MT Newswires

22 days ago

Argus Downgrades Biogen to Hold From Buy

BIIB

Argus Research

22 days ago

Analyst Report: Biogen Inc

BIIB

Argus Research

22 days ago

Market Digest: APD, BIIB, BJ, CNP, FE

Biogen (NasdaqGS:BIIB) Gets US FDA Fast Track For Alzheimer's Despite US$8M Settlement
BIIB

Simply Wall St.

23 days ago

Biogen (NasdaqGS:BIIB) Gets US FDA Fast Track For Alzheimer's Despite US$8M Settlement

BIIB's Experimental Alzheimer's Drug Gets FDA Fast Track Tag
BIIB

Zacks

23 days ago

BIIB's Experimental Alzheimer's Drug Gets FDA Fast Track Tag

BIIB

MT Newswires

23 days ago

RBC Trims Price Target on Biogen to $221 From $225, Keeps Outperform Rating

Organon acquires Actemra biosimilar’s US rights from Biogen
BIIB

Pharmaceutical Technology

24 days ago

Organon acquires Actemra biosimilar’s US rights from Biogen

BIIB

MT Newswires

24 days ago

Biogen Says Investigational Alzheimer's Drug Receives FDA Fast Track Designation

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease
BIIB

GlobeNewswire

24 days ago

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

BIIB

MT Newswires

25 days ago

Organon Acquires Tofidence for Intravenous Infusion in US

Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years
BIIB

Simply Wall St.

25 days ago

Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years

Lilly hits same Alzheimer’s roadblock in Europe as Eisai, Biogen
BIIB

BioPharma Dive

a month ago

Lilly hits same Alzheimer’s roadblock in Europe as Eisai, Biogen

BIIB

MT Newswires

a month ago

Biogen Signs Lease for New Global HQ in Cambridge, Massachusetts

3 Value Stocks Walking a Fine Line
BIIB

StockStory

a month ago

3 Value Stocks Walking a Fine Line

Biogen plots new global headquarters in Kendall Square
BIIB

BioPharma Dive

a month ago

Biogen plots new global headquarters in Kendall Square

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square
BIIB

GlobeNewswire

a month ago

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

Axsome (AXSM) Down 0.8% Since Last Earnings Report: Can It Rebound?
BIIB

Zacks

a month ago

Axsome (AXSM) Down 0.8% Since Last Earnings Report: Can It Rebound?

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks
BIIB

StockStory

a month ago

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Biogen Inc. (BIIB): Among the Most Undervalued Biotech Stocks to Invest In
BIIB

Insider Monkey

a month ago

Biogen Inc. (BIIB): Among the Most Undervalued Biotech Stocks to Invest In

Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia
BIIB

Pharmaceutical Technology

a month ago

Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia

Why Is Biogen (BIIB) Up 1.1% Since Last Earnings Report?
BIIB

Zacks

a month ago

Why Is Biogen (BIIB) Up 1.1% Since Last Earnings Report?

Can BIIB's New Drugs Revive Growth as Multiple Sclerosis Sales Fall?
BIIB

Zacks

a month ago

Can BIIB's New Drugs Revive Growth as Multiple Sclerosis Sales Fall?

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant
BIIB

Zacks

a month ago

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV
BIIB

BioPharma Dive

a month ago

A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV

Biogen begins dosing in trial of felzartamab for kidney transplant patients with AMR
BIIB

Clinical Trials Arena

a month ago

Biogen begins dosing in trial of felzartamab for kidney transplant patients with AMR

BIIB

MT Newswires

2 months ago

Biogen Initiates Dosing of Phase 3 Study of Felzartamab

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
BIIB

GlobeNewswire

2 months ago

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

Is Eli Lilly Stock A Buy As It Plays Ball With Trump To The Tune Of $27 Billion?
BIIB

Investor's Business Daily

2 months ago

Is Eli Lilly Stock A Buy As It Plays Ball With Trump To The Tune Of $27 Billion?

Tariffs Send Investors to Safety of Food, Drug and Utility Stocks
BIIB

The Wall Street Journal

2 months ago

Tariffs Send Investors to Safety of Food, Drug and Utility Stocks

New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach
BIIB

Pharma Voice

2 months ago

New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach

BIIB

MT Newswires

2 months ago

Biogen's Alzheimer's Treatment Lecanemab Denied Approval in Australia

3 Reasons BIIB is Risky and 1 Stock to Buy Instead
BIIB

StockStory

2 months ago

3 Reasons BIIB is Risky and 1 Stock to Buy Instead

BIIB

MT Newswires

2 months ago

Biogen, Eisai Say EMA Panel Reaffirms Positive Opinion on Lecanemab

The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
BIIB

PR Newswire

2 months ago

The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease

Biogen Inc. (BIIB): Among the Stocks That Will Go to The Moon According to Analysts
BIIB

Insider Monkey

2 months ago

Biogen Inc. (BIIB): Among the Stocks That Will Go to The Moon According to Analysts

NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
BIIB

Benzinga

2 months ago

NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects

Biogen Inc. (BIIB): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
BIIB

Insider Monkey

2 months ago

Biogen Inc. (BIIB): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Biogen and Stoke Therapeutics to commercialise Dravet syndrome treatment
BIIB

Pharmaceutical Technology

2 months ago

Biogen and Stoke Therapeutics to commercialise Dravet syndrome treatment

We Think Biogen's (NASDAQ:BIIB) Healthy Earnings Might Be Conservative
BIIB

Simply Wall St.

2 months ago

We Think Biogen's (NASDAQ:BIIB) Healthy Earnings Might Be Conservative

Biogen Strengthens Pipeline With Stoke Therapeutic's Dravet Syndrome Candidate Via Multi-Million Dollar Deal
BIIB

Benzinga

2 months ago

Biogen Strengthens Pipeline With Stoke Therapeutic's Dravet Syndrome Candidate Via Multi-Million Dollar Deal

BIIB

MT Newswires

2 months ago

Bernstein Adjusts Price Target on Biogen to $159 From $160, Keeps Market Perform Rating

BIIB

MT Newswires

2 months ago

Piper Sandler Adjusts Price Target on Biogen to $135 From $138, Keeps Neutral Rating

BIIB

MT Newswires

2 months ago

Biogen, Stoke Partner on Dravet Syndrome Investigational Drug Zorevunersen

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
BIIB

Business Wire

2 months ago

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments

Biogen buys rights to Stoke’s rare epilepsy drug
BIIB

BioPharma Dive

2 months ago

Biogen buys rights to Stoke’s rare epilepsy drug

BIIB

MT Newswires

2 months ago

Guggenheim Cuts Biogen Price Target to $168 From $190

Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts
BIIB

Benzinga

2 months ago

Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts

BIIB

MT Newswires

2 months ago

Biogen Still Offering Value, RBC Says

Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance
BIIB

Zacks

2 months ago

Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance

Sage Therapeutics price target lowered to $12 from $14 at Scotiabank
BIIB

TipRanks

2 months ago

Sage Therapeutics price target lowered to $12 from $14 at Scotiabank

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline
BIIB

BioPharma Dive

2 months ago

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

BIIB

MT Newswires

2 months ago

Truist Securities Adjusts Price Target on Biogen to $210 From $220, Keeps Buy Rating

BIIB

MT Newswires

2 months ago

Scotiabank Adjusts Biogen Price Target to $224 From $244

BIIB

MT Newswires

2 months ago

Wedbush Adjusts Biogen Price Target to $135 From $166

Biogen expects 2025 profit decline despite strong Q4
BIIB

Yahoo Finance Video

2 months ago

Biogen expects 2025 profit decline despite strong Q4

Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
BIIB

Benzinga

2 months ago

Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma

BIIB

MT Newswires

2 months ago

Royalty Pharma to Provide up to $250 Million to Biogen for Litifilimab R&D

Biogen Inc. (BIIB) Q4 Earnings and Revenues Surpass Estimates
BIIB

Zacks

2 months ago

Biogen Inc. (BIIB) Q4 Earnings and Revenues Surpass Estimates

Biogen’s (NASDAQ:BIIB) Q4 Sales Top Estimates
BIIB

StockStory

2 months ago

Biogen’s (NASDAQ:BIIB) Q4 Sales Top Estimates

BIIB

MT Newswires

2 months ago

Biogen's Q4 Non-GAAP Earnings, Revenue Rise; 2025 Outlook Set

Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
BIIB

Reuters

2 months ago

Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition

Why Investors Might Hammer Biogen Despite Its Earnings Beat
BIIB

Investor's Business Daily

2 months ago

Why Investors Might Hammer Biogen Despite Its Earnings Beat

BIIB

Investing.com

2 months ago

Bernstein starts Biogen at ‘market-perform,’ notes near term uncertainty

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
BIIB

StockStory

2 months ago

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

BIIB

MT Newswires

2 months ago

Bernstein Initiates Biogen at Market Perform With $160 Price Target

Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?
BIIB

Zacks

3 months ago

Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?

Why Biogen Inc. (BIIB) Is Among the Best Healthcare Stocks To Buy According to Analysts
BIIB

Insider Monkey

3 months ago

Why Biogen Inc. (BIIB) Is Among the Best Healthcare Stocks To Buy According to Analysts

Seeking Clues to Biogen (BIIB) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
BIIB

Zacks

3 months ago

Seeking Clues to Biogen (BIIB) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Genentech eyes lupus market for Gazyva with positive Phase III data readout
BIIB

Pharmaceutical Technology

3 months ago

Genentech eyes lupus market for Gazyva with positive Phase III data readout

Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
BIIB

Zacks

3 months ago

Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth

Lilly’s investigational Alzheimer’s to be investigated in prevention trial
BIIB

Clinical Trials Arena

3 months ago

Lilly’s investigational Alzheimer’s to be investigated in prevention trial

Biogen Stock Down on Regulatory Update in the EU for Alzheimer's Drug
BIIB

Zacks

3 months ago

Biogen Stock Down on Regulatory Update in the EU for Alzheimer's Drug

Why Are Analysts Bullish on Biogen Inc. (BIIB) Now?
BIIB

Insider Monkey

3 months ago

Why Are Analysts Bullish on Biogen Inc. (BIIB) Now?

BIIB

MT Newswires

3 months ago

Biogen, Eisai Say EU Panel Set to Discuss Additional Safety Data on Lecanemab

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
BIIB

GlobeNewswire

3 months ago

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Share on Social Networks: